Project: Inhibition of antimicrobial drug resistance: Exploiting an old drug as a basis for inhibitory discovery

Acronym	INHIBITION (Reference Number: JPIAMR_2016_N013)
Duration	01/01/2017 - 31/12/2017
Project Topic	Antimicrobial resistance (AMR) is a serious emerging threat for patients and the healthcare systems. It has been anticipated by the Institute and Faculty of Actuaries in Britain that AMR has the potential to reduce Gross Domestic Product (GDP) by 3.5% globally and to kill an additional 10 million people by 2050, and as such the topic is of high importance to the public. Our working group will highlight the efforts made in the field by academics and industry alike and raise awareness on the urgency of action and proposes the use of an old nitrofuran drug for future development of potent antimicrobials by intense study of its use, potency, and the fundamental science behind its mode of action and resistance mechanisms. The inclusion of distinguished and prominent scientists in the field coming from different backgrounds will emphasize a multidisciplinary effort is needed to tackle the serious problem of AMR in a timely fashion.
Website	visit project website
Network	JPI AMR
Call	4th Joint Call: Research Networking Programmes

Project partner

Number	Name	Role	Country
1	Goethe University Frankfurt	Coordinator	Germany
2	University of Birmingham	Observer	United Kingdom
3	Uppsala University	Observer	Sweden
4	Erasmus MC University Medical Center	Observer	Netherlands
5	University of Birmingham	Observer	United Kingdom
6	University of Birmingham	Observer	United Kingdom
7	University of Birmingham	Observer	United Kingdom
8	Goethe University Frankfurt	Observer	Germany
9	Goethe University Frankfurt	Observer	Germany
10	DaVolterra	Observer	France